Astrocytes elicit transient Ca 2+ elevations induced by G protein-coupled receptors (GPCRs), yet 30 their role in vivo remains unknown. To address this, transgenic mice with astrocytic expression 31 of the optogenetic Gq-type GPCR, Optoα1AR, were established, in which transient Ca 2+ 32 elevations similar to those in wild type mice were induced by brief blue light illumination. 33
Introduction

42
Interfacing both synapses and blood vessels, astrocytes' prime functions in the brain have been 43 recognized as the maintenance of extracellular environment and the transfer of energy substrates. 44 Additionally, studies in the recent decade have presented compelling evidence that astrocytes 45 modulate neuronal activity by various mechanisms. Central to the astrocyte-mediated 46 modulation of neuronal activity is Ca 2+ elevation of astrocytes. While electrically passive, 47
astrocytes elicit large-amplitude cytosolic Ca 2+ elevations that are triggered by G 48 protein-coupled receptors (GPCRs), particularly the Gq-type, which activate the inositol 49 trisphosphate (IP 3 ) pathway. Amongst Gq-GPCRs, the alpha-1 adrenergic receptor (α1AR) has 50 been identified to be the prevalent receptor for brain-wide astrocytic Ca 2+ elevations, responding 51 to locus coeruleus (LC) activation in awake mice 1,2 . 52
On the vascular side, astrocytic Ca 2+ elevation has been implicated in the modulation of local 53 cerebral blood flow 3-5 . However, astrocytic modulation of local cerebral blood flow has been 54 questioned since IP 3 receptor type-2 knockout mice (IP 3 R2-KO), in which large astrocytic Ca 2+ 55 elevations are diminished, display a similar extent of functional hyperemia 6,7 . The controversy 56 remains unresolved to date. For instance, recent studies that make use of genetic Ca 2+ indicators 57
are not in support of astrocytic modulation of blood flow 8,9 , while another study suggests 58 modulation via pericytes 10 . 59 A considerable amount of literature suggests modulation of synaptic transmission and plasticity 60 by astrocytic Ca 2+ elevation [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . On the other hand, there are a few studies that report negative 61 results 21, 22 . Moreover, a study that performed a behavioral test battery reported no obvious 62 phenotype in astrocyte-specific IP 3 R2-KO mice 23 . Recently, however, the use of synthetic 63
GPCRs (i.e. DREADDs) permitted astrocyte-specific pharmacogenetic activation of Gq 64 signaling. While an initial study that targeted brain-wide astrocytes did not find a phenotype in 65 motor learning 24 , recent studies reported phenotypes in aversive learning by amygdalar or 66 hippocampal astrocytic activation 25, 26 . However, pharmacogenetic activation of astrocytes 67
inevitably leads to hour-long activation of astrocytes, hence the role of physiological activation 68 of astrocytes in behaving mice has remained unaddressed. Here, we generated transgenic mouse 69 lines in which astrocytes express the optogenetically activated Gq-GPCR Optoα1AR 27 that 70 permits transient elevation of astrocytic Ca 2+ by blue light in inflammation-free conditions. 71 72
Results
73
Transgenic mice with selective astrocytic expression of Optoα1AR 74 We have generated transgenic mice in which Optoα1AR 27 is expressed under the control of a 75 BAC-GLT1 promoter 28 (Fig. 1a) . Among the 11 GLT1-Optoα1AR-EYFP founders, a few lines 76 showed astrocyte-specific expression. We examined two lines, #941 and #877, in this study. 77
Line #941 showed ubiquitous expression of Optoα1AR-EYFP in astrocytes throughout the brain 78 ( Fig. 1b; Sup. 1a ), whereas line #877 had expression in a sparse population of astrocytes ( Fig.  79 1c; Sup. 1b). EYFP fluorescence in the cortex of line #941 was twice as strong as that of line 80 #877 (195.3 ± 9.0% of 9 strong TG mice relative to 100 ± 7.8% of 10 patchy TG mice; 81 p<0.0001, unpaired t-test). Accordingly, #941 and #877 are referred to as "strong" and "patchy" 82 TG mice, respectively. Immunohistochemistry with astrocytic (S100β), neuronal (NeuN) and 83 microglial (Iba1) markers showed that Optoα1AR-EYFP was expressed in astrocytes (strong 84 TG: 76.9 ± 3.3%, S100β-positive 448 cells, 4 mice; patchy TG: 49.1 ± 2.8%, 476 cells, 4 mice). 85 EYFP expression was negligible in neurons (strong TG: 8.3 ± 1.7%, NeuN-positive 2463 cells, 86 4 mice; patchy TG: 1.4 ± 0.6%, 2177 cells, 4 mice) and microglia (strong TG: 1.4 ± 0.8%, 87
IbaI-positive 142 cells, 4 mice; patchy TG: 1.6 ± 0.9%, 151 cells, 4 mice) in the cortex (Sup. 1a 88 and b). Cortical GFAP and IbaI expressions were generally low in wild type (WT), strong and 89 patchy TG mice (Sup. 1c, GFAP, strong TG: 89.5 ± 3.9%, patchy TG: 87.5 ± 2.4%, relative to 90
WT: 100 ± 6.2%. Sup. 1d, IbaI, strong TG: 89.2 ± 4.5%, patchy TG: 87.1 ± 3.6%, relative to 91 WT: 100 ± 5.7%, n = 4 mice for all groups). Fine ramified microglial processes were 92 prevalently observed in IbaI immunohistochemistry (Sup. 1a and b), suggesting that the 93 expression of the foreign protein does not cause glial inflammation in these TG lines. 94
Next, we performed in vivo Ca 2+ imaging from superficial layers of the cortex in 95 urethane-anesthetized patchy TG mice. Cortical astrocytes were loaded with the red Ca 2+ 96 indicator Rhod-2 and observed by two-photon microscopy (Fig. 1d) . Optoα1AR-positive 97 astrocytes were distinguishable by their EYFP fluorescence, allowing simultaneous 98 investigation of Optoα1AR-positive and -negative astrocytes ( Fig. 1e-g, insets) . Activation of 99 the vertebrate rhodopsin-based GPCRs including the Optoα1AR requires cis-retinal, which is 100 converted to trans-retinal and released upon activation 29, 30 . Consistent with low levels of 101 endogenous cis-retinal in the cortex, blue light illumination did not induce Ca 2+ elevations in 102
Optoα1AR-positive astrocytes even when power and duration of the blue light were increased 103 ( Fig. 1e ). Next, we repeated the experiment with a supplement of 9-cis-retinal by i.p. injection. 104
Notably, systemic 9-cis-retinal administration enabled reliable photoactivation of Optoα1AR 105 ( Fig. 1f and . 1f and h) . 111
Remarkably, more intense illumination (1 s, 1 mW) gave rise to Ca 2+ elevations in 112
Optoα1AR-negative astrocytes ( Fig. 1g . 1j ) 115 and rise time (onset to peak: 4.92 ± 0.51 s vs 9.28 ± 1.29 s; Fig. 1k ). The decay time was also 116 longer in positive astrocytes (peak to offset: 36.7 ± 2.76 s vs 21.8 ± 2.90 s; Fig. 1l ). 117
We compared optically evoked astrocytic Ca 2+ The following experiments therefore were performed with retinal pretreatment by i.p. injection 141 (see methods) unless otherwise noted. 142
Astrocytic Gq signaling does not induce artery dilation 143
To test whether astrocytic Gq signaling mimicking salient sensory stimulation has a causal 144 impact on local cerebral blood flow, we performed two-photon imaging of the vasculature in the 145 somatosensory cortex of urethane-anesthetized strong TG mice (Fig. 2a) . The vasculature was 146 labeled by i.v. FITC injection, and astrocytes were loaded with Rhod-2. First, we confirmed that 147 brief forelimb stimulation (2 s) induces penetrating artery dilation in the corresponding primary 148 somatosensory cortex. The arterial cross section expanded immediately after stimulus onset and 149 reached to a peak within three seconds. Thereafter, the arterial cross section area gradually 150 decreased to baseline in five seconds. This response was stereotypical and repeatable ( Fig. 2b) . 151 Sensory stimulation was given at an interval of thirty seconds and the degree of artery 152 expansion did not significantly differ between the first three and the last three trials of the nine 153 consecutive trials (p>0.7, paired t-test). Overall, the relative area increase of arteries in the first 154 3 seconds after stimulus onset was 12.1±0.9% (17 arteries, 5 mice, Fig. 2c ). On the other hand, 155 arterial area increase in the hindlimb somatosensory cortex was negligible (1.9±0.6%, 4 arteries, 156 2 mice), suggesting that the arterial dilation was locally induced. Astrocytic endfoot Ca 2+ 157 elevations were only occasionally observed after sensory stimulation (occurrence probability = 158 10/100 = 10 %; 10 endfeet, 3 mice). On average, endfoot Ca 2+ increase (F/F 0 ) of 12±5% was 159 observed in the averaged plot with a latency of several seconds ( Fig. 2d) . 160
Having demonstrated reliable functional hyperemia in arteries of the somatosensory area, we 161 examined if optically evoked Gq-driven astrocytic Ca 2+ increase impacts vasomodulation in the 162 same set of arteries. As in figure 2a, a brief illumination of blue light (1 s, 1 mW) through the 163 objective lens was given while arterial cross sections and astrocytic Ca 2+ were imaged. We 164 observed that arterial cross section areas remained unchanged despite optical stimulation ( Fig.  165 2e), while Ca 2+ elevations at astrocytic endfeet were reliably evoked ( Fig. 2f) . The lack of 166 arterial cross section change was in stark contrast with sensory-induced hyperemia ( Fig. 2g) , in 167 spite of significant Ca 2+ increases in the astrocytic endfeet by optogenetic Gq-GPCR stimulation 168 ( Fig. 2h) neuronal Ca 2+ activity quantified as the standard deviation (std) of somatic F/F 0 jRGECO1a 176 ( Fig. 3a and Sup. Movie 3). This somatic activity reduction was detectable during the first 1 177 min ( Fig. 3c ; jRGECO1a F/F 0 std relative to pre-LED 1 min period: 83.0±4.3%; p<0.008) and 178 continued for an additional minute ( Fig. 3c ; 88.2±3.3%; p<0.02). Similar Ca 2+ activity reduction 179 was also detected in the neuropil ( Fig. 3a and c; post-LED 1 min period: 84.1±5.1%; p<0.03; 180 post-LED 1-2 min period: 90.9±3.2%; p<0.03). These suppressive effects could not be 181 attributed to possible photodamage by the two-photon laser or a sensory processing of the LED 182 light, as WT mice did not display such a reduction ( Fig. 3b ; soma, post-LED 1 min period: 183 98.0±5.0%; p>0.70), which was significantly different from TG (p<0.05, unpaired t-test). 184 Among the molecules released by astrocytic activation, adenosine exerts inhibitory effects 185 through the adenosine A1 receptor (A1R) 25, 35, 36 . When the A1R antagonist, CPT, was applied, 186 this astrocytic Optoα1AR-induced neuronal suppression disappeared and a trend for neuronal 187 activation was observed ( Fig. 3d To examine the effect of astrocytic Gq activation on sensory evoked neuronal activity, we 194 performed in vivo field potential (FP) recording from somatosensory cortex layer 2/3 under 195 shallow isoflurane anesthesia (~0.8%) ( Fig. 3e) . After stable FP response for sensory 196 stimulation on the trunk was obtained, brief LED illuminations were delivered from the pial 197 surface above the recording site through optical fiber (φ = 0.2 mm, 1 mW, duration 1 s, interval 198 5 min, 6 times). As a result, evoked FP slope was decreased after the LED illumination in TG 199 mice, while it was unchanged in WT mice (Fig. 3f) . This reduction was rapidly expressed and 200 lasting ( Fig. 3f . 4a ). As demonstrated in a 220 single-animal example in figure 4a, the TG mouse had a sign of lower exploratory behavior 221 than the WT mouse. To check the level of anxiety, time in center domain was quantified, and 222 there was not a significant difference between WT and TG mice in any of the trichotomized 223 time intervals ( Fig. 4b) . Locomotion was consistently lower in optically stimulated TG mice 224 throughout the course of the open field test and the difference from WT mice became more 225 significant in the middle and final 15 min periods ( Fig. 4c and d) . Analysis of immobile time 226
shows that TG mice gradually develop immobility and the difference from WT mice becomes 227 distinct in the last 20 min period ( Fig. 4e) . 228
Time-averaged analysis of locomotion with respect to LED illumination indicates that the 229 transient astrocytic Gq activation reduced the locomotion activity rapidly. This reduced activity 230 continued until the next astrocytic Gq activation ( Fig. 4f) . Therefore, the astrocytic Gq 231 signal-triggered reduction of locomotion accumulated at every LED illumination, resulting in 232 larger locomotion differences detected in later periods ( Fig. 4c and d) . Notably, when the A1R 233
antagonist DPCPX was applied at the dosage that does not affect open field locomotion in WT 234 mice 41, 42 (1 mg/kg), the reduced locomotion in the strong TG mice by LED illumination was 235 reverted ( Fig. 4d and f) . Patchy TG mice showed a similar trend for reduced locomotion 236 activity, although the degree of reduction was smaller (Sup. 4), suggesting that thorough 237 activation of astrocytic Gq signaling is required for the decreased locomotion. Consistently, 238
insufficient Gq activation without retinal supply could not induce the locomotion decrease (Sup. 239 5). 240
Next, we examined the influence of astrocytic Gq signaling on memory. Anterior cortical areas 241
including the prefrontal cortex have been shown to regulate memory acquisition and 242 maintenance [43] [44] [45] , which could be mediated by noradrenergic input 46 . To evaluate the 243 involvement of astrocytic Gq activation in working memory, we performed the Y-maze test. 244
Both strong TG and WT mice freely explored in the Y-maze for 15 min while receiving blue 245 LED stimulation (duration 3 s, interval 3 min, 5 times; Fig. 5a ). The probability of the correct 246 arm entry (i.e. the entry to the arm different from the current and immediate prior ones) did not 247 change significantly between TG and WT mice, although its variability was higher in TG mice 248 ( Fig. 5b) . The number of arm entries, total distance traveled and immobile time were also 249 similar between TG and WT mice ( Fig. 5c-e ). These results indicated that the transient 250 astrocytic Gq signal activation in anterior cortical areas does not affect working memory or alter 251 the short-term exploratory behavior in the Y-maze. 252
We then tested long-term memory by performing the novel object recognition test. On day 1, 253
anterior cortical areas were illuminated with LED (duration 3 s, interval 3 min, 4 times) during 254 the object familiarization period (training period), whereby two identical objects located apart 255
were exposed for 10 min in a behavior chamber. When one of the pre-exposed objects was 256 replaced with a novel object 1 day later ( Fig. 6a left) , WT and strong TG mice similarly spent a 257 longer time contacting the novel object relative to the familiar object ( Fig. 6a middle) . Notably, 258
when object replacement was done 14 days later ( Fig. 6a left) , TG mice still retained the novel 259 object preference, whereas WT mice lost the preference ( Fig. 6a right) . Even if the duration of 260 each LED illumination was increased from 3 s to 30 s ( Fig. 6b) , TG mice showed a similar 261 novel object preference 14 days later, suggesting that 3 s activation is sufficient to achieve the 262 plateaued enhancement in object memory retention. Of note, LED illumination of TG mice 263 without retinal supply could not significantly induce this 14-day memory retention ( Fig. 6c ), 264 consistent with insufficient Gq activation. Moreover, LED illumination of TG mice with 265 DPCPX treatment did not result in 14-day memory retention, although the novel object 266 recognition after 1 day was normal ( Fig. 6d) . These experiments suggest that transient 267 activation of astrocytic Gq signal does not affect memory acquisition but enhances memory that 268 lasts for more than two weeks through A1R activation. 269
Previous studies showed that systemic injection of noradrenaline (NA) immediately after 270 training enhances long-term object recognition memory 47, 48 . To test if astrocytic Gq activation 271 induces similar effects, we photo-stimulated TG mice immediately after training (duration 3 s, 272
interval 3 min, 4 times; Sup. 6a) and found that this post activation was also effective for 273 memory enhancement 14 days later (Sup. 6a right). Unlike prolonged exposure to an open 274 environment ( Fig. 4) , neither locomotion nor object contact time differed significantly during 275 the 10 min training period across genotypes, illumination durations or drug applications (Sup. 276 6b and c). Furthermore, the memory-enhancing effect is not due to an avoidance behavior from 277 familiarized objects which were associated with astrocytic Gq activation, as the conditioned 278 place preference test suggests that astrocytic Gq activation did not change environmental 279 preference to activated side or non-activated side (Sup. 7). 280
Discussion
281
The identification of the optogenetic stimulation conditions for the Optoα1AR TG mice allowed 282 causal assessment of physiological Gq signaling in astrocytes for the first time. While Gq 283 activation in astrocytes did not affect arterial diameter, it transiently inhibited local neuronal 284 activity via adenosine A1 receptor, induced depression of evoked response when paired with 285 sensory stimuli, and reduced locomotor activity. Furthermore, transient astrocytic Gq signaling 286 enhanced long-term memory (LTM) while short-term memory (STM) was not affected. 287
Astrocytic Gq signaling is not involved in arterial dilation. 288 We demonstrated that sensory stimulation causes artery dilation and occasional astrocytic 289 endfoot Ca 2+ elevation. However, optogenetically triggered Ca 2+ elevations via Optoα1AR in 290 the same set of perivascular astrocytes did not result in vessel dilation (Fig. 2) . Cortical 291 hyperemia has been demonstrated to be actuated by smooth muscle cells 49 and capillary dilation 292
precedes that of upstream arteries 50 . While we did not examine capillary diameters in this study, 293
the lack of the arterial expansion argues against the involvement of astrocytic Gq signal-induced 294
Ca 2+ elevation in the control of arterial diameter in sensory-evoked functional hyperemia. 295
Neuronally evoked capillary dilatation may be controlled by endfoot Ca 2+ entry 51 possibly 296 through P2X channels 10 . 297 298 Astrocytic Gq signaling-induced neuronal inhibition 299 Effects of astrocytic Gq activation on neuronal activity remains controversial. For instance, in a 300 recent pharmacogenetic study 26 and an optogenetic study 52 , astrocytic Gq activation induced 301 long-term potentiation (LTP) in hippocampal CA1 slices, but an earlier pharmacogenetic study 302 reported no effects 21 . Whereas these studies did not report in vivo effects on astrocytic and 303 neuronal activity, we showed rapid reduction of neuronal activity and depression of evoked 304 response after astrocytic Gq activation ( Fig. 3) in the cortex 20 . The apparent difference of plasticity expression may be explained by the 314 manner whereby GPCR is activated. Volume-transmitted neuromodulators act on neuronal and 315 astrocytic GPCRs, both of which may be required for the synaptic potentiation. Likewise, these 316 neuromodulators also activate Gs and/or Gi/o signaling, that may also play an essential role. 317 Importantly, the current study selectively stimulates astrocytic Gq signaling in a temporally 318 defined manner, thereby dissecting specific roles of the signaling in the neural circuit. 319 320 Astrocytic Gq signaling-induced behavioral changes 321 We found that transient astrocytic Gq activation in wide anterior cortical areas gradually 322 attenuated locomotion in a novel open field ( Fig. 4) , which is consistent with its neuronal 323 suppressive effects ( Fig. 3) . While noradrenergic activation is generally thought to promote 324 arousal, a study showed that LC noradrenergic neuronal discharge pattern modulates locomotor 325 activity: Phasic high-frequency bursts decrease locomotor activity, and tonic low-frequency 326 discharges increase locomotion 58 . Astrocytic Gq signaling-induced long-term memory enhancement 336 The absence of effects on STM by the astrocytic Gq signal activation in our study ( Fig. 5 ) 337 contrasts with earlier studies that showed an impairment of spatial STM by infusion of α 1AR 338
agonists in the prefrontal cortex 59,60 or an enhancement of STM in T-maze by pharmacogenetic 339 activation of hippocampal CA1 26 . This inconsistency could be due to a combination of multiple 340 factors including activation area (global anterior cortex vs local hippocampal CA1), activation 341 mode (transient vs sustained), and astrocytic Ca 2+ response magnitude. For the last point, our 342 optogenetic activation results in Ca 2+ elevations similar to natural astrocytic responses ( Fig. 1) , 343 whereas other studies did not address this issue. 344
We showed that the astrocytic Gq signal activation did not affect object recognition memory 345 retrieval one day after learning, whereas it enhanced memory two weeks after (Fig. 6) . In 346 contrast, the pharmacogenetic astrocytic Gq signal activation has been reported to enhance 347 1-day memory in a contextual fear conditioning task 26 . Adamsky and colleagues also showed 348 that continuous 5-min illumination of astrocytic Optoα1AR (90% duty cycle) similarly induced 349 a 1-day memory enhancement; however, comparison with our result is difficult due to the lack 350 of description for in vivo astrocytic Ca 2+ elevation and cis-retinal supplement, aside from the 351 learning-paradigm difference. Another recent study showed that 3-min illumination of 352 melanopsin expressed in CA1 astrocytes induced a memory enhancement in an object place test 353 probed 30-min after association 52 . However, direct comparison to our result is difficult due to 354 the lack of in vivo activation data as well as the concern that the melanopsin (Opn4-human) used 355
in the study activates the Gi/o pathway in addition to the Gq pathway 61 Astrocytic Gq signaling-mediated novelty detection 362 LTM enhancement by brief astrocytic activation during or shortly after object familiarization 363 (Fig. 6, Sup. 6 Synaptic depression has been suggested as a key mechanism for novelty detection and memory 382 [76] [77] [78] . NA application to acute brain slices induced long-term depression (LTD) in an 383 α 1AR-dependent manner 79,80 , which is presumably mediated by astrocytic ATP release 81 . 384 Moreover, phasic stimulations of LC in vivo induced β AR-dependent LTD in the hippocampus 385 82 . Notably, serum response factor (SRF)-deficient mice are impaired of hippocampal LTD and 386
do not habituate to novel environments 83 . Our results of synaptic depression and reduced 387 locomotion by astrocytic Gq activation ( Fig. 3 and 4) pulsed-field gel analysis of restriction digestions and direct sequencing of the insert. The 414 linearized BAC DNA was purified, adjusted to be ~1 ng/µl in a microinjection buffer (10 mM  415 Tris-Cl, 0.1mM EDTA, 100mM NaCl, pH 7.4), and individually injected into the pronuclei of 416 445 C57BL/6J-fertilized embryos. As a result, 81 founders were born, of which 11 founders 417
were positive for the transgene. Positive founder mice were identified by 301 bp DNA amplified 418 by PCR using the following primer pair: 5' CGAGGCGCTAAAGGGCTTACC 3' and 5' 419 CCCCAGCATAATCAGAAGGA 3'. Positive founder mice were crossed with C57BL/6J mice 420 and maintained on this genetic background. The established 11 line gave astrocytic expression 421 of Optoα1AR-EYFP with different expression strengths and variable positive cell proportion. 422
Among them, the two lines, #941 and #877, were selected based on the selective expression of 423
Optoα1AR-EYFP in astrocytes and used in the current study as strong TG and patchy TG mice, 424
respectively. These heterozygous mice were crossed with C57BL/6J mice to obtain 425 heterozygous mice for experiments and were noted as TG mice. 426 427 Immunohistochemistry 428 Mice were transcardially perfused with 4% paraformaldehyde in 0.1 M phosphate buffer. 429
Coronal sections of 60 μ m thickness across AP ~-1.5 mm were obtained. These sections were 430 incubated with anti-S100β ( 
In vivo two-photon Ca 2+ imaging of astrocytes
438 Adult Optoα1AR patchy TG mice (>2 months old) were anesthetized with 1.5 g/kg urethane. A 439 metal frame was attached to the skull using a dental acrylic (Fuji LUTE BC, GC and Super  440 Bond, Sun Medical), and a craniotomy (diameter 2.0-3.0 mm) for imaging was made above the 441 somatosensory cortex (AP -1.5 to -2.5 mm and ML 1.5 to 2.5 mm). The dura mater was 442 carefully removed, and the exposed cortex was loaded with Rhod-2 AM (0.4 mM, Molecular Rhod-2 responses were reliably observed ~30 min after 9-cis-Retinal injection and thereafter for 464 ~1.5 hr. LED illuminations were repeated at ~9 min interval. Tail pinch was manually applied 465 via blunt tongs for ~1 s. 466
For long-term Ca 2+ imaging, RCaMP1.07 was selectively expressed in astrocytes under the 467 control of a GFAP promoter. Optoα1AR strong TG mice (>2 months old) were anesthetized 468 with ketamine and xylazine (56 and 8 mg/kg, respectively) and a metal frame was attached to 469 the skull. A small craniotomy was made above the somatosensory cortex and a glass 470 micropipette containing AAV9-hGFAP-RCaMP1.07 (3.0-4.0 × 10 12 vg/ml, PBS) was inserted 471 to a depth of 300 μ m below the pial surface. Microinjection of 300 nl was made over 3 min 472 using a Femtojet injector (~5 psi, Eppendorf), and the exposed cortical surface was covered by a 473 sterilized round cover glass (3 or 4 mm in diameter) to be used as a cranial window for later 474 imaging. 475 >2 weeks later, AAV-microinjected mice were anesthetized with 1.5 g/kg urethane, and RCaMP 476
imaging was performed using the Bergamo two-photon microscope with 1040 -60 nm laser. In 477 these experiments, the same region was repeatedly imaged before and after LED illuminations 478
(1 mW) with different durations (1 s, 3 s or 3 min) at 9 min interval. For 3 min illumination, 1.5 479 s LED-on and 0.5 s LED-off, were repeated. RCaMP signals were first imaged without 480 9-cis-Retinal addition. Thereafter, 9-cis-Retinal was supplemented by i.p. injection, and imaging 481 was resumed after 40 min. For testing the repeatability of 1-s Optoα1AR activation, LED 482 illuminations were repeated at 3-min intervals in addition to 9-min interval. 483
484
In vivo two-photon imaging of blood vessels 485 Metal frames were attached to the skull of anesthetized adult Optoα1AR strong TG mice (>2 486 months old, 1.0 g/kg urethane and 50 mg/kg α -chloralose). A small craniotomy was made above 487 the somatosensory cortex (AP -1.0 to 1.0 mm and ML 1.5 to 3.5 mm). The serum was labeled 488 by intravenous injection of FITC-dextran (2 MDa, Sigma). Needles (30 G) were inserted in the 489 contralateral forelimb to apply sensory stimulation (1 mA, 100 ms, 3 Hz, 6 times, interval 30 s, 490 10 times). Vasculature imaging was performed after 9-cis-Retinal i.p. injection using the 491
Bergamo microscope (820 nm). Once sensory-driven vasodilation was observed, the same area 492
was imaged with Optoα1AR activation by LED illumination (1 mW, duration 1s). In some mice 493
(3 out of 5 mice), astrocytic Rhod-2 loading in the somatosensory cortex was also done. 494
Simultaneous imaging of astrocytic endfoot Ca 2+ and the vasculature was performed using the 495
Bergamo microscope with 820 nm laser. For analysis of FITC area, penetrating arterioles that 496
have circular cross-sections were sampled. 497
498
In vivo two-photon Ca 2+ imaging of neurons 499 AAV1.Syn.NES-jRGECO1a.WPRE.SV40 (Penn Vector Core, 3.4 -5.7 x 10 12 vg/ml) was 500 injected at a depth of 300 μ m of the somatosensory cortex of adult WT and Optoα1AR strong 501 TG mice, as above. Following >2 weeks recovery, mice were imaged using the Bergamo 502 microscope with 1040-60 nm laser at a frame rate of 5 Hz in anesthetized (1.5 g/kg urethane) or 503 awake condition. In the latter case, mice were trained to be restrained under the microscope 504 using a mechanical fixture that rigidly fixes the head frame once a day for 5-7 days. During this 505 training, mice were water-deprived, and had access to water once the head frame is fixed to the 506 apparatus, thereby making an association between the head fixture and satiation of thirst. In 507 both anesthetized and awake conditions, 9-cis-Retinal i.p. injection was made ~40 min before 508
imaging. Optoα1AR was activated by LED (1 mW, 1 s), which was repeated 4 to 8 times at 509 9-min interval. In some TG mice, adenosine A1R antagonist, CPT (C102, Sigma) was 510 administered (20 mg/kg, i.p., dissolved at 40 mM in DMSO) 60 min before optogenetic 511 stimulation. 512
513
In vivo local field potential recording 514 Adult WT and Optoα1AR strong TG mice (>2 months old) were anesthetized with isoflurane 515
(1.5%). A metal frame was attached to the skull and mice were rigidly fixed in a headplate 516 holding device. A craniotomy was made above the somatosensory cortex. A glass micropipette 517
(2 μ m tip diameter, 1B150F-4, World Precision Instruments) filled with HEPES-ACSF was 518 placed to an electrode holder with a headstage preamplifier. The headstage is then mounted to a 519 remote-controlled micromanipulator (EMM-3NV, Narishige). Under a stereo microscope, the 520 glass micropipette was inserted to the primary somatosensory cortex, trunk region (AP ~-1.5 521 mm, ML ~1.7 mm and DV ~0.25 mm) 87 . An optical fiber (200 μ m diameter, CFML22L10, 522
Thorlabs) connected to 470 nm LED devices (LEDFRJ-B_FC and LEDRV_1CH_1000, Doric) 523 was placed over the pial surface above the recording site. Two vitrodes (L150, Nihon Kohden) 524
were put on the both sides of the dorsal trunk to apply sensory stimulation (1.5 mA, duration 1 525 ms, interval 10 s). After 9-cis-Retinal i.p. injection, isoflurane dosage was decreased to ~0.8 %. 526
Thereafter, the room light was turned off. 527
After sensory evoked response was stabilized (typically ~1 hr), evoked field potential recording 528 began (Multiclamp 700B, Axon instruments; 1000 x, 0.1 Hz to 3 kHz, digitized at 10 kHz using 529 a LabVIEW-based data acquisition system, National Instruments). After stable evoked field 530 potential response was obtained, brief LED illuminations were delivered above the recording 531 site (1mW, duration 1 s, interval 5 min, 6 times). for 10 min, where two identical objects were fixed 20 cm apart on the plywood with 556 double-sided adhesive tape (SRE-19, 3M). Three different objects of similar size were used in a 557
counter-balanced manner, as the role (familiar vs novel object) as well as the position (left or 558 right) were randomly permuted. Transient LED illuminations (duration 3 s, interval 3 min, 4 559 times) or longer LED illuminations (duration 30 s, interval 3 min, 4 times) were delivered 560 during the training period. Immediately after training, mice were returned to the home cage, and 561 LED-receiver and -battery were detached from mice 10 min later. In post-activation 562 experiments, LED illuminations (duration 3 s, interval 3 min, 4 times) were delivered during 563 this 10 min in the home cage immediately after training. On the test day, (1 day or 14 days after  564 training), mice were exposed to one of the pre-familiarized objects and a novel object for 10 565 min without LED illumination. In some TG mice, DPCPX was i.p.-injected at the dosage of 1 566 mg/kg, ~60 min before LED illuminations. 567
Conditioned place preference test: The conditioned place preference apparatus consisted of 568 three chambers. The left and right chambers have the same size (25 × 25 cm) but were 569 distinguished by their walls with vertical-stripes or horizontal-stripes, respectively. The center 570 chamber (25 × 15 cm) has neutral walls without stripe. This test consisted of three different 571
phases: pre-test, conditioning and post-test. On day 1 (for pre-test), individual mice were placed 572 in the center chamber and allowed to freely enter and explore the three chambers for 20 min 573 without LED illumination to measure default place preference. On day 2 to 5 (for conditioning), 574 mice pre-treated with 9-cis-Retinal were confined for 30 min to either the left or right chamber 575
on alternate days, and LED illuminations (duration 3 s, interval 3 min, 10 times) were delivered 576 in either the left or right chamber. Days with LED illuminations (day 2 and day 4 or day 3 and 577 day 5) were counterbalanced. On day 6 (for post-test), mice were again placed in the center 578 chamber and allowed to freely enter and explore the three chambers for 20 min without LED 579 illumination to measure the post-conditioning place preference. Post-test and pre-test were 580 conducted identically. 581 582 Data analysis 583 Immunohistochemistry: Quantifications (Sup. 1) were performed from layer 1 to 6 in both 584 sides of 500 µm-wide somatosensory cortex (ML ~1.5-2.0 mm). Among the cellular 585 marker-positive cells, EYFP-positive or EYFP-negative cells were manually counted from 60 x 586 images at single plane. Intensity of GFAP, IbaI or EYFP of the above somatosensory cortical 587 area was measured by ImageJ software from stack images acquired with a 10× objective over 60 588 μ m-thick brain slices. Measured intensity of GFAP or IbaI of a mouse was normalized by mean 589 intensity of WT mice and presented as relative intensity in Sup. 1c or 1d. Measured intensity of 590 EYFP of a TG mouse was first subtracted by mean intensity of WT mice which corresponds to 591 background EYFP intensity. The subtracted value was then divided by the mean intensity of 592 patchy TG mice and described as relative percent to patchy TG mice in the text. 593 Two-photon imaging: Analysis was performed by ImageJ and MATLAB software. Image shift 594 in xy axis was adjusted by the TurboReg ImageJ plug-in program for all images. 595
Rhod-2 and RCaMP signals in astrocytes ( Fig. 1 and Sup. 2) were extracted from cell bodies 596 manually on ImageJ, and these intensity data in region of interests (ROIs) were exported to 597 MATLAB software for further analysis of F/F 0 , where F is fluorescence intensity within a given 598 ROI at each time point and F 0 is the mean fluorescence intensity within a given ROI during 0-1 599 min before LED illumination. A responsive cell was defined as a cell exhibiting >120 % F/ F 0 600
for >10 s within 30 s after LED illumination. Peak F/F 0 , onset time, peak time and offset time 601
were analyzed for responsive cells. Onset time is the time firstly reaching 120 % F/ F 0 . Offset 602 time is a time firstly returning to 120 % F/ F 0 after peak. The values in each image were 603 averaged across ROIs, and these normalized values were presented in Fig. 1 and Sup. 2. 604 FITC signals (Fig. 2) were binarized and circular cross-sections of penetrating arterioles were 605 extracted using ImageJ. The binarized data were used to calculate the cross-section area using 606 MATLAB. Astrocytic endfeet area was manually marked in the neighborhood of the penetrating 607 arterioles and Rhod-2 signals were extracted accordingly using ImageJ. Rhod-2 signals were 608
analyzed by MATLAB to calculate of F/F 0 . The values of FITC and Rhod-2 were averaged 609 across imaging trials and normalized to the control period of 0-10 s before sensory stimulation 610 or LED illumination. Mean ± SEM of the normalized trace is presented in Fig. 2 c-f . Mean of 611 this normalized value from 0 to 5 s and this peak value from 0 to 20 s after sensory stimulation 612 or LED illumination were presented in Fig. 2 g and h . 613 RGECO signals in neurons ( Fig. 3 and Sup. 3) were extracted from cell bodies and neuropils 614 manually on ImageJ, and these intensity data were analyzed by MATLAB to calculate F/F 0 and 615 standard deviation (std) of F/F 0 in each ROI. These stds were averaged across ROIs and then 616 further averaged across imaging trials. The mean std in each mouse was normalized by that in 617 0-1 min before LED illumination as 1, and this normalized value was presented as relative 618
RGECO std in Fig. 3 and Sup. 3. 619
Local field potential recording: The slope of evoked LFP (Fig. 3) was calculated by 620 MATLAB as described previously 16, 20 . First, the initial deflection of the LFP response was 621 isolated. Next, the region for slope calculation was defined as the interval within 20 to 80% of 622 the peak-to-peak amplitude of the negative deflection. The slope was computed by linear 623 regression of the selected region. LFP slope within 1 min bin in each mouse was averaged with 624 regard to 6 times LEDs, and this mean value was normalized by that in 0-1 min before LED 625 illumination as 1, and this normalized value was presented as relative FP slope in Fig. 3f . 626 Averaged LFP slope within 5 min bin in each mouse was normalized by that in 0-5 min before 627 LED illumination as 1, and this normalized value was presented as relative FP slope in Fig. 3g . 628
Behavioral experiments: The entire sessions in behavioral experiments were recorded by a 629 video camera (C910, Logicool). Animal's body position was determined by Any-maze behavior 630 tracking software (Stoelting) . Regarding novel open field test ( Fig. 4, Sup. 4 and Sup. 5), time 631
in the center zone (central 20 x 20 cm), total traveled distance and immobile time were 632 calculated by Any-maze software. Speed of traveled distance in each mouse was averaged with 633 regard to 15 times LEDs, and this mean value was normalized by that in 0-20 s before LED 634 illumination as 1, and this normalized value was presented as relative speed in Fig. 4f . 635
Regarding Y-maze test (Fig. 5) , total number of arm entries and correct arm entry (the entry to 636 the arm different from the current and immediate prior ones) were determined from the recorded 637 video. Total traveled distance and immobile time were measured by Any-maze software. 638
Regarding novel object recognition test ( Fig. 6 and Sup. 6) , contact time was defined as time in 639 touching the objects with nose or forepaws, which was determined from the recorded video. 640
Relative contact is a ratio of contact time to a replaced object (F2 or N in Fig. 6 increase. Time 0 corresponds to onset time, when F/F 0 reaches 120 %. 920 (N) Peak amplitude was similar among the 3 groups (p> 0.32, one-way ANOVA). 921 (O and P) Onset-to-peak and peak-to-offset times of Ca 2+ expressing jRGECO1a (RGECO) in neurons by AAV-Syn-jRGECO1a (left). RGECO F/F 0 965 from the labeled somata (1-6) and neuropil (N) decreased rapidly after 1 s LED illumination 966 (middle). Ca 2+ activity, measured as the standard deviation (std) of RGECO F/F 0 , decreased in 967 the first and the second 1 min after LED illumination (right). Scale bars: 20 μ m (micrograph); 968 100 % F/F 0 and 1 min (traces). 969 (B) Ca 2+ activity of neuronal somata and neuropil in WT mice did not change after LED 970 illumination (p>0.70 and p>0.80, paired t-test, 1 min after LED illumination vs 1 min before 971 LED illumination, 8 mice). 972 (C) Ca 2+ activity of neuronal somata and neuropil in TG mice decreased in the first and second 973 minutes after LED illumination (first minute: p<0.008 and p<0.03; second minute: p<0.02 and 974 p<0.03, paired t-test vs 1 min before LED illumination, 7 mice). 975 (D) Adenosine A1R antagonist CPT blocked Optoα1AR-induced neuronal Ca 2+ activity 976 decrease in somata and neuropil (p>0.18 and p>0.25, paired t-test, 1 min after LED illumination 977 vs 1 min before LED illumination, 6 mice). 978 (E-G) Sensory evoked field potential (FP) recording in somatosensory cortex layer 2/3 of 979 shallowly anesthetized mice upon LED illumination. 980 (E) FP response was evoked by sensory stimulation to the trunk (duration 1 ms, interval 10 s) 981 before and after brief LED illumination (1 mW, duration 1 s). Six optical stimulations (5 min 982 interval) were performed in a session. 983 (F) LED time-triggered averaging of FP slope shows a reduction of sensory evoked response 984 after astrocytic Gq activation in the first 1 min (p<0.008, paired t-test vs 1 min before LED 985 illumination, 6 TG mice). WT mice did not show a significant change in FP slope (p>0.51, 986 paired t-test vs 1 min before LED illumination, 7 WT mice). This reduction in TG mice was 987 detectable 3 min after LED illumination (p<0.008, paired t-test vs 1 min before LED 988 illumination, 6 TG mice). Insets: averaged FP traces from a representative mouse, with the left 989 and right traces averaged within 1 min before and 1 min after LED illumination, respectively. 990
Scale-bars: 200 μ V and 20 ms. 991 (G) In the 30 min recording, evoked FP slope gradually decreased in TG mice (20-25 min and 992 25-30 min periods: p<0.004 and <0.05, paired t-test vs 0-10 min before LED illumination, 6 TG 993 mice), while that in WT mice did not change throughout the 30 min period (p>0.1, paired t-test 994 vs 0-10 min before LED illumination, 7 WT mice). Insets: averaged FP traces from a 995 representative mouse, with the left and right trace averaged within the 5 min period before the 996 first LED illumination and the 5 min period after the last LED illumination, respectively. Scale 
